REGULATION OF SINUSOIDAL PERFUSION IN SHOCK
REGULATION OF SINUSOIDAL PERFUSION IN SHOCK
批准号:
6476154
负责人:
MARK G CLEMENS
金额:
$19.11万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-04-01 至 2005-11-30
关键词:
cell type cellular pathology endothelin enzyme activity flow cytometry gene expression hormone receptor immunofluorescence technique inflammation isozymes laboratory mouse laboratory rat liver cells liver circulation disorder liver disorder liver ischemia /hypoxia microcirculation nitric oxide synthase oxidative stress oxygen consumption polymerase chain reaction receptor expression septic shock stress proteins western blottings
中文摘要
描述(逐字摘自申请人的摘要)血管改变
肝脏微循环的反应是肝脏的一个主要决定因素
对氧化或炎症应激的反应。这种血管反应是
主要由应激相关血管调节基因的诱导所介导:
内皮素及其受体和一氧化氮合酶(NOS)。这个
这项提议的长期目标是阐明通过什么机制
临床相关后血管反应改变对肝损伤的调节作用
应激,如内毒素血症和败血症。短期目标是测试
假设肝血管对内毒素或脓毒症的反应
是通过上调内皮素B受体和相互作用介导的
这些受体与一氧化氮合酶有关。为了检验这一假设,有四个
提出了具体的目标:1.确定内皮素的相对贡献
应激后微血管反应中的受体亚型。这一目标将
使用一系列特异的内皮素激动剂和拮抗剂来解剖
内皮素受体亚型对生理学的特殊贡献
回答2.确定改变的表达的细胞类型分布
应激条件下的内皮素、内皮素受体和一氧化氮合酶亚型。
这一目标将阐明特定的细胞类型(内皮细胞、库普弗细胞
细胞、星状细胞、肝细胞和中性粒细胞)
内皮素受体。此外,腺泡状细胞的表达分布
具体的细胞类型将被确定。3.测试更改后的假设
内皮型一氧化氮合酶(ENOS)的调节参与了内皮素活性的升高。
这一目标将首先表征eNOS的表达和活性。
特定的细胞类型和腺泡位置,然后测试生理反应
过度表达(使用辛伐他汀或腺病毒基因转移)或
缺失(使用具有靶向突变的小鼠)以确定一氧化氮合酶在
内毒素或脓毒症后调节内皮素敏感性。4.测试是否
特异性肝血管应激的表达或作用的调控
蛋白质导致氧气供应和氧气供应之间的微区域平衡中断
需求与肝细胞损伤。这一目的将评估生理
收缩/扩张平衡关系的意义
以目标1-3为特征。这将使用新的方法来实现
在上一次筹资期间开发,以量化空间分布
肝脏中氧输送和代谢反应的高分辨率
活着。
英文摘要
DESCRIPTION (Verbatim from the applicant's abstract) Alterations in vascular
response of the liver microcirculation is a major determinant of the liver's
response to oxidative or inflammatory stress. This vascular response is
mediated largely by the induction of the stress-related vasoregulatory genes:
the endothelins and endothelin receptors and nitric oxide synthase (NOS). The
long term objective of this proposal is to elucidate the mechanisms by which
altered vascular responses modulate hepatic injury after clinically relevant
stresses such as endotoxemia and sepsis. The short term objective is to test
the hypothesis that that the hepatic vascular response to endotoxin or sepsis
is mediated by upregulation of endothelin B receptors and the interaction of
these receptors with nitric oxide synthase. To test this hypothesis, four
specific aims are proposed: 1. Define the relative contribution of endothelin
receptor subtypes in the microvascular response following stress. This aim will
use a series of specific endothelin agonists and antagonists to dissect out the
specific contributions of endothelin receptor subtypes to the physiologic
response 2. Determine cell-type distribution of altered expression of
endothelins, endothelin receptors and NOS isoforms following stress conditions.
This aim will elucidate the specific cell types (endothelial cell, Kupffer
cell, stellate cell, hepatocyte and neutrophil) that express specific
endothelin receptors. Additionally, the acinar distribution of expression in
specific cell types will be determined. 3. Test the hypothesis that altered
regulation of eNOS contributes to the hyperse aboutzsitivity to endothelins.
This aim will first characterize the expression and activity of eNOS in
specific cell types and acinar locations and then test the physiologic response
to either over expression (using simvastatin or adenovirus gene transfer) or
deletion (using mice with targeted mutations) to determine the role of NOS in
modulating endothelin sensitivity follow endotoxin or sepsis. 4. Test whether
manipulation of the expression or action of specific hepatic vascular stress
proteins results in disruption of microregional balance between O2 supply and
demand and hepatocellular injury. This aim will evaluate the physiologic
significance of the relationships among the constrictor / dilator balance
characterized in aims 1-3. This will be accomplished using novel methodologies
developed in the previous funding period to quantify the spatial distribution
of oxygen delivery and metabolic response in the liver with high resolution in
vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhanced production of human hepatocytes from livers declined for transplant
-
批准号:9140604
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2016
-
负责人:MARK G CLEMENS
-
依托单位:
Human hepatocytes for drug toxicity screening from Cardiac Death Donor livers
-
批准号:8314669
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2012
-
负责人:MARK G CLEMENS
-
依托单位:
Regulation of sinusoidal perfusion in shock
-
批准号:7849427
-
项目类别:
-
资助金额:$3.73万
-
财政年份:2009
-
负责人:MARK G CLEMENS
-
依托单位:
Regulation of sinusoidal perfusion in shock
-
批准号:7902654
-
项目类别:
-
资助金额:$10.33万
-
财政年份:2009
-
负责人:MARK G CLEMENS
-
依托单位:
Automated analysis of NKT cell sentry pattern in liver with metastatic tumor
-
批准号:7197547
-
项目类别:
-
资助金额:$21.54万
-
财政年份:2007
-
负责人:MARK G CLEMENS
-
依托单位:
Automated analysis of NKT cell sentry pattern in liver with metastatic tumor
-
批准号:7347610
-
项目类别:
-
资助金额:$14.4万
-
财政年份:2007
-
负责人:MARK G CLEMENS
-
依托单位:
Recovery /preservation of donation cardiac death livers
-
批准号:7052654
-
项目类别:
-
资助金额:$20.55万
-
财政年份:2006
-
负责人:MARK G CLEMENS
-
依托单位:
Alcohol as a modulator of prefibrotic liver injury
-
批准号:6532405
-
项目类别:
-
资助金额:$6.5万
-
财政年份:2001
-
负责人:MARK G CLEMENS
-
依托单位:
Engineering aspects of liver support systems
-
批准号:6617830
-
项目类别:
-
资助金额:$42.37万
-
财政年份:2001
-
负责人:MARK G CLEMENS
-
依托单位:
Engineering aspects of liver support systems
-
批准号:6788025
-
项目类别:
-
资助金额:$43.64万
-
财政年份:2001
-
负责人:MARK G CLEMENS
-
依托单位:
Engineering aspects of liver support systems
-
批准号:6524322
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2001
-
负责人:MARK G CLEMENS
-
依托单位:
Alcohol as a modulator of prefibrotic liver injury
-
批准号:6361787
-
项目类别:
-
资助金额:$6.5万
-
财政年份:2001
-
负责人:MARK G CLEMENS
-
依托单位:
Engineering aspects of liver support systems
-
批准号:6339830
-
项目类别:
-
资助金额:$50.46万
-
财政年份:2001
-
负责人:MARK G CLEMENS
-
依托单位:
Engineering aspects of liver support systems
-
批准号:6918763
-
项目类别:
-
资助金额:$44.95万
-
财政年份:2001
-
负责人:MARK G CLEMENS
-
依托单位:
PHARMACOLOGIC AGENTS FOR PRESERVATION OF DONOR LIVERS
-
批准号:3237473
-
项目类别:
-
资助金额:$18.33万
-
财政年份:1986
-
负责人:MARK G CLEMENS
-
依托单位:
REGULATION OF HEPATIC SINUSOIDAL PERFUSION IN SHOCK
-
批准号:2608414
-
项目类别:
-
资助金额:$16.03万
-
财政年份:1986
-
负责人:MARK G CLEMENS
-
依托单位:
REGULATION OF HEPATIC SINUSOIDAL PERFUSION IN SHOCK
-
批准号:2388049
-
项目类别:
-
资助金额:$15.41万
-
财政年份:1986
-
负责人:MARK G CLEMENS
-
依托单位:
PHARMACOLOGIC AGENTS FOR PRESERVATION OF DONOR LIVERS
-
批准号:3237466
-
项目类别:
-
资助金额:$18.26万
-
财政年份:1986
-
负责人:MARK G CLEMENS
-
依托单位:
PHARMACOLOGIC AGENTS FOR THE PRESERVATION OF DONOR LIVER
-
批准号:3237474
-
项目类别:
-
资助金额:$12.17万
-
财政年份:1986
-
负责人:MARK G CLEMENS
-
依托单位:
PHARMACOLOGIC AGENTS FOR PRESERVATION OF DONOR LIVERS
-
批准号:3237472
-
项目类别:
-
资助金额:$17.23万
-
财政年份:1986
-
负责人:MARK G CLEMENS
-
依托单位:
海外基金